The clinicomolecular landscape of de novo versus relapsed stage IV metastatic breast cancer.
CONCLUSION: The comparative tumour landscape revealed significant clinical, pathological and molecular differences between dnMBC and rMBC, indicating that dnMBC may be a separate biological entity to rMBC at the primary level with differing paths to metastasis. Additionally, we provided a list of potential serum biomarkers that may be useful in detecting dnMBC in its pre-metastatic window if such a window exists.
PMID: 32067942 [PubMed - as supplied by publisher]
Source: Experimental and Molecular Pathology - Category: Pathology Authors: Seltzer S, Corrigan M, O'Reilly S Tags: Exp Mol Pathol Source Type: research
More News: Biology | Breast Cancer | Cancer | Cancer & Oncology | Genetics | Hormones | Mammography | Molecular Biology | Pathology | Study